| 标题 |
Abstract CT216: IMpower150 final analysis: Efficacy of atezolizumab (atezo) + bevacizumab (bev) and chemotherapy in first-line (1L) metastatic nonsquamous (nsq) non-small cell lung cancer (NSCLC) across key subgroups |
| 网址 | |
| DOI |
10.1158/1538-7445.am2020-ct216
doi
|
| 其它 |
期刊:Cancer Research 作者:Mark A. Socinski; Tony S. Mok; Makoto Nishio; Robert M. Jotte; Federico Cappuzzo; et al 出版日期:2020-09-04 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)